Cure Pharmaceutical and Milagro Pharmaceuticals announced their collaboration to register and sell in Mexico a number of CURE's OTC and medical compounds that utilize CUREform, CURE's patented drug delivery platform for oral thin film. Cure is in discussions with several large distributors in Mexico and Latin America. OTF products that will be marketed and sold in Mexico via key distribution partners include CUREfilm Blue - an oral soluble form of sildenafil citrate for the treatment of erectile dysfunction.

Vitamin D3 - that provides a convenient, weekly 40,000 IU dose of Vitamin D An electrolyte energy boost - that provides a healthier, sugar-free alternative to energy drinks Sleep - a dose of melatonin that dissolves on the tongue so it can be taken even after the user climb into bed. The opportunity to serve the Latin American market with this venture into Mexico is an exciting one that is expected to accelerate the ramp up of CURE's FDA-registered, cGMP manufacturing facility, where the Company pioneered and developed its patented CUREfilm, drug delivery platform. The Company expects to select a distribution partner for the LATAM territory in the coming months.